2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10175
Neoplasms
7806
Carcinoma, Non-Small-Cell Lung
5749
Prostatic Neoplasms
5022
Colorectal Neoplasms
4599
Lung Neoplasms
3720
Leukemia, Myeloid, Acute
3100
Neoplasm Metastasis
3080
Multiple Myeloma
3078
Pancreatic Neoplasms
2841
Melanoma
2650
Ovarian Neoplasms
2571
Lymphoma
2570
Carcinoma, Hepatocellular
2478
Stomach Neoplasms
2329
Recurrence
2226
Head and Neck Neoplasms
2098
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2085
Lymphoma, Non-Hodgkin
2057
Leukemia
2012
Brain Neoplasms
1900
Glioblastoma
1793
Colonic Neoplasms
1790
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Rectal Neoplasms
1718
Uterine Cervical Neoplasms
1689
Squamous Cell Carcinoma of Head and Neck
1652
Lymphoma, Follicular
1651
Lymphoma, Large B-Cell, Diffuse
1597
Carcinoma, Renal Cell
1576
Interventions
Mifepristone
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Gulf War Illness
×
Clear all
NCT04254627
2025-02-19
E/M
Nova Southeastern University
Phase 1
Active not recruiting
20 enrolled